CN2528018Y - ToRCH protein chip - Google Patents
ToRCH protein chip Download PDFInfo
- Publication number
- CN2528018Y CN2528018Y CN 01263165 CN01263165U CN2528018Y CN 2528018 Y CN2528018 Y CN 2528018Y CN 01263165 CN01263165 CN 01263165 CN 01263165 U CN01263165 U CN 01263165U CN 2528018 Y CN2528018 Y CN 2528018Y
- Authority
- CN
- China
- Prior art keywords
- torch
- protein
- film
- chip
- microslide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The utility model discloses a ToRCH protein chip belonging to the technical field of biochip. The protein chip comprises a glass slide; a macromolecule xylanase membrane is adhered to the glass slide; the surface of macromolecule xylanase membrane is adhered with a ToRCH antigen-antibody protein microarray. All ToRCH diagnosis can be completed by a chip at one time in a short time of about 2 hours, which is very convenient and fast; the cost is much lower than that of the examination of imported kit. Therefore, as the utility model is released, the popularity of ToRCH disease examination and diagnosis will be promoted, which will have vital and far-reaching significance for the good prenatal and postnatal care and the improvement of the quality of newborn population in China, even in the entire world.
Description
Technical field
The utility model relates to a kind of protein-chip, and especially a kind of protein-chip of diagnosing usefulness belongs to the biochip technology field.
Background technology
Nineteen nineties, a brand-new era is brought biotechnology in biochip research at the very start.Compare with the genetic chip that causes extensive concern, protein-chip can reflect the protein level in the biosome, therefore can express more complete biological information.
" ToRCH " is the technical term of modern perinatal medicine.Wherein, T represents toxoplasma gondii (Toxoplasmagondii), O represents (Other) such as Epstein-Barr virus, HIV virus and human parvovirus B19s, R represents rubella virus (Rubella Virus), C represents cytomegalovirus (Cytomegalovirus), and H represents herpes simplex I type and II type virus (Herpes Simplex Virus I and II).The scope of these pathogenic infections is wide, harm is big, and the pregnant woman is easy to take place primary infection, causes miscarriage, premature labor, stillborn foetus or growth retardation of fetus and developmental deformity, thus the population quality of having a strong impact on.
Developed countries such as America and Europe just classify it as pregnancy period examination project as far back as the seventies.Pregnant earlier T oRCH testing, especially Beijing have also progressively been carried out in China developed regions, and municipal government has issued the relevant document of ToRCH being classified as pregnant woman's routine inspection project.
At present, the complete dependence on import of kit of China ToRCH deagnostic test, it costs an arm and a leg, because the every box reagent of kit need use up in the short as far as possible time, therefore requires the number of inspection simultaneously and the dosage coupling of every box reagent.The person under inspection need spend 300-500 unit, usually will wait for that there is the result in several old name for the Arabian countries in the Middle Easts.Expensive inspection charge and loaded down with trivial details scrutiny program have limited popularizing that ToRCH checks to a great extent.
The purpose of this utility model is: at the problem of above-mentioned existing ToRCH deagnostic test reagent existence, utilize the high-tech biotechnology to propose a kind of ToRCH protein-chip, thereby the diagnosis that makes the ToRCH disease has more science, checks the diagnostic means method easily, can generally accept for hospital, patient.
In order to reach the foregoing invention purpose, the technical solution of the utility model is: the ToRCH protein-chip comprises microslide, and described microslide is attached with macromolecule glycan film, and described macromolecule glycan film surface attachment has ToRCH antigen-antibody protein microarray.
During inspection, be coated on clearly on the chip of the present utility model as long as will wait to have a blood test, if the person under inspection is by the ToRCH virus infections, its serum will be very fast with chip on corresponding antigen-antibody generation idiosyncrasy, when by fluorescence microscope, just show corresponding positive feature, like this in the short time about two hours, just can finish all ToRCH diagnosis by a slice chip is disposable, very convenient quick, its cost is significantly less than the expense that the import reagent box is checked.Therefore, after technology of the present utility model is released, will greatly promote popularizing of ToRCH disease examination, to the prenatal and postnatal care and the important and far-reaching meaning of raising newborn population quality generation in the China and even the world.
Description of drawings
Below in conjunction with accompanying drawing the technical solution of the utility model is described further.
Fig. 1 is the structural representation of technical solutions of the utility model embodiment one.
Embodiment
Embodiment one
The ToRCH protein-chip of present embodiment adopts glass as microslide 1, the upper surface of microslide 1 is attached with one deck agarose film 2, the upper surface point of agarose film 2 has ToRCH antigen protein microarray 3, and point has ToRCH antibody 4 (referring to Fig. 1) on the ToRCH antigen microarray 3.
Embodiment two
The ToRCH protein-chip of present embodiment adopts silicon chip as microslide 1, the upper surface of microslide 1 is attached with one deck glucosan---polyacrylamide film 2, the upper surface point of glucosan---polyacrylamide film 2 has ToRCH antigen protein microarray 3, and point has ToRCH antibody 4 on the ToRCH antigen microarray 3.
During inspection, be coated on clearly on the chip as long as will wait to have a blood test, in short time about two hours, just can finish all ToRCH diagnosis by a slice chip is disposable, very conveniently fast experimental results show that, its sensitivity and specificity are all very good, and its cost only is 30% of an import reagent box inspection charge.Therefore, after the release, will have very vast market prospect, have a tremendous social and economic benefits.
In addition to the implementation, the technical solution of the utility model also has other numerous embodiments.For example, microslide adopts Ge, GaAs, GaP, SiO2, Si3N4 sheet, or gel, glycan thing such as poly-tetrafluoro, poly-alum, polycarbonate; Macromolecule glycan film is an agarose---polyacrylamide base film or agarose---glucosan---polyacrylamide base film etc.; All employings are equal to the technical scheme of replacement or equivalent transformation formation, are the protection domain of the utility model requirement.
Claims (6)
1. a ToRCH protein-chip comprises microslide, it is characterized in that: described microslide is attached with macromolecule glycan film, and described macromolecule glycan film surface attachment has ToRCH antigen-antibody protein microarray.
2. ToRCH protein-chip according to claim 1 is characterized in that: described macromolecule glycan film upper surface point has ToRCH antigen protein microarray, and point has ToRCH antibody on the ToRCH antigen microarray.
3. ToRCH protein-chip according to claim 1 and 2 is characterized in that: described microslide is a glass, and the upper surface of described glass slide is attached with one deck agarose film.
4. ToRCH protein-chip according to claim 1 and 2 is characterized in that: described microslide is a silicon chip, and the upper surface of silicon chip microslide is attached with one deck glucosan---the polyacrylamide film.
5. according to claim 2 or 3 described ToRCH protein-chips, it is characterized in that: described microslide adopts Ge, GaAs, GaP, SiO2, Si3N4 sheet, or the gel glycan thing of poly-tetrafluoro, poly-alum, polycarbonate.
6. ToRCH protein-chip according to claim 1 is characterized in that: described macromolecule glycan film is an agarose---polyacrylamide film or agarose---glucosan---polyacrylamide film.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01263165 CN2528018Y (en) | 2001-10-11 | 2001-10-11 | ToRCH protein chip |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01263165 CN2528018Y (en) | 2001-10-11 | 2001-10-11 | ToRCH protein chip |
Publications (1)
Publication Number | Publication Date |
---|---|
CN2528018Y true CN2528018Y (en) | 2002-12-25 |
Family
ID=33670798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 01263165 Expired - Fee Related CN2528018Y (en) | 2001-10-11 | 2001-10-11 | ToRCH protein chip |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN2528018Y (en) |
-
2001
- 2001-10-11 CN CN 01263165 patent/CN2528018Y/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pelloux et al. | Determination of anti–Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux) | |
Stray-Pedersen et al. | The prevalence of toxoplasma antibodies among 11 736 pregnant women in Norway | |
ATE161960T1 (en) | ISOLATION OF FETAL CELLS FROM MATERNAL BLOOD TO PERFORM PRENATAL DIAGNOSTICS | |
JP2002504222A (en) | In situ immunodetection of antigen | |
CN1122614A (en) | Method and device for detecting or measuring the amount of a cell-associated molecule | |
JPH08500181A (en) | Screening method for Down's syndrome using dried blood samples | |
Tissot Dupont et al. | Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis | |
EP0670042A4 (en) | Immunoassays for antibodies in urine to microorganisms associated with sexually transmitted diseases. | |
US20210349105A1 (en) | Sars-cov-2 immunoassay and materials therefor | |
Ketema et al. | Assessment of the performance of a rapid, lateral flow assay for the detection of antibodies to HIV | |
CN104155449A (en) | Method and kit for detecting TORCH IgM antibodies and preparation method of kit | |
KR920007686B1 (en) | Extraction composition test kit and their use to extract or determine herpes simplex viral antigen | |
CN2528018Y (en) | ToRCH protein chip | |
CN1869700A (en) | Sterility, infertility six-index integral investigating reaction plate and protein chip kit | |
CN111781360A (en) | Free cell capture probes and related products and uses | |
CN1412557A (en) | ToRCH protein chip and its preparation method | |
Taylor et al. | Comparison of the ADVIA centaur® and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory | |
JP2009515169A (en) | Methods for determination of antibody IgG binding activity | |
JP2013527467A5 (en) | ||
CN2486973Y (en) | Multiple combined fast detection reagent box | |
CA1231047A (en) | Diagnostic test for rheumatological diseases | |
Hamai et al. | Quantitative Assessment of Human Leukocyte Antigen‐G Protein in Amniotic Fluid by a Double‐Determinant Enzyme‐Linked Immunosorbent Assay Using Anti‐Human Leukocyte Antigen‐G‐Specific Antibody ‘87G’ | |
US20070160978A1 (en) | Method for seriological diagnosis and determination of immunisation status, comprising various controls | |
WO2003023403A1 (en) | A KIT FOR THE SIMULTANEOUS DIAGNOSIS OF FOUR KINDS OF DISEASES (ToRCH) RESULTING IN DEFORMITY FETUS AND A METHOD FOR PREPARATION OF IT | |
EP2200620A1 (en) | Infectious disease testing of menstrual fluid, endometrial /menstrual cells, amniotic fluid, umbilical cord blood or other samples |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |